Bio

Blane is a Partner at Talisman Capital Partners. Blane was the founder of inChord Communications, Inc., which he built into the largest independently-owned, healthcare communications company in the world. In 2005, inChord was acquired by Ventiv Health, the largest provider of outsourced sales and clinical services serving the pharmaceutical industry to create inVentiv Health. In 2008, Blane became CEO of the combined public company. Through organic growth and more than 20 acquisitions, inVentiv Health became the leading provider of outsourced product development and commercialization services to the global pharmaceutical and life sciences industries. inVentiv's client roster consists of more than 350 leading pharmaceutical, biotech, life sciences and healthcare companies. In 2010, Mr. Walter led the successful $1.2 billion buyout of inVentiv Health by Thomas H. Lee Partners. Blane served as Vice Chairman of inVentiv Health and also served as Chairman of the Governor of Ohio’s Executive Workforce Board. Blane is Chairman of the Board of Columbus College of Art and Design as well as a member of the Board of Helius Medical Techonologies, Inc. (NASDAQ:HSDT). Prior to joining inChord, Mr. Walter worked as a Financial Analyst in New York City for Smith Barney in mergers and acquisitions specialty group. Blane actively pursues and manages investments in healthcare, information technology and marketing/professional services. Mr. Walter graduated Summa Cum Laude with a BS in Marketing and Finance from Boston College.